Term Name: | 1-O-(4-O-benzyl-alpha-D-galactosyl)-N-hexacosanoylphytosphingosine |
---|---|
Synonyms: | (2S,3S,4R)-1-(4-O-benzyl-alpha-D-galactopyranosyloxy)-2-hexacosanoylaminooctadecane-3,4-diol, N-[(1S,2S,3R)-2,3-dihydroxy-1-({[4-O-(phenylmethyl)-alpha-D-galactopyranosyl]oxy}methyl)heptadecyl]hexacosanamide, N-[(1S,2S,3R)-2,3-dihydroxy-1-[[[4-O-(phenylmethyl)-alpha-D-galactopyranosyl]oxy]methyl]heptadecyl]hexacosanamide, N-[(2S,3S,4R)-1-(4-O-benzyl-alpha-D-galactopyranosyloxy)-3,4-dihydroxyoctadecan-2-yl]hexacosanamide, N-[(2S,3S,4R)-1-(4-O-benzyl-alpha-D-galactosyloxy)-3,4-dihydroxyoctadecan-2-yl]hexacosanamide, N-{(2S,3S,4R)-1-[(4-O-benzyl-alpha-D-galactopyranosyl)oxy]-3,4-dihydroxyoctadecan-2-yl}hexacosanamide |
Definition: | A glycophytoceramide having a 4-O-benzyl-alpha-D-galactosyl residue at the O-1 position and a hexacosanoyl group attached to the nitrogen. One of a series of an extensive set of 4"-O-alkylated alpha-GalCer analogues evaluated (PMID:30556652) as invariant natural killer T-cell (iNKT) antigens. |
Ontology: | ChEBI [CHEBI:145426] ( EBI ) |